4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-017640
EVP Research & Development sold 2,000 shares at $32.91 ($65,820)
- EVP Research & Development acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Malik Fady Ibraham · EVP Research & Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,000 | $10.60 | $21,200 | 142,610 | D |
| 2025-06-17 | Sale : show line 2 in the form 10b5-1 | −2,000 | $32.91 | $65,820 | 140,610 | D |
| Open-market sales · 2,000 sh · avg $32.91 · $65,820 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-17 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −2,000 | 17,105 | D |
Loading xslF345X05/form4.xml…